Skip to main content
Erschienen in: European Radiology 12/2016

25.04.2016 | Breast

Incidentally detected enhancing lesions found in breast MRI: analysis of apparent diffusion coefficient and T2 signal intensity significantly improves specificity

verfasst von: Otso Arponen, Amro Masarwah, Anna Sutela, Mikko Taina, Mervi Könönen, Reijo Sironen, Juhana Hakumäki, Ritva Vanninen, Mazen Sudah

Erschienen in: European Radiology | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To evaluate the value of adding T2- and diffusion-weighted imaging (DWI) to the BI-RADS® classification in MRI-detected lesions.

Methods

This retrospective study included 112 consecutive patients who underwent 3.0T structural breast MRI with T2- and DWI on the basis of EUSOMA recommendations. Morphological and kinetic features, T2 signal intensity (T2 SI) and apparent diffusion coefficient (ADC) findings were assessed.

Results

Thirty-three (29.5 %) patients (mean age 57.0 ± 12.7 years) had 36 primarily MRI-detected incidental lesions of which 16 (44.4 %) proved to be malignant. No single morphological or kinetic feature was associated with malignancy. Both low T2 SI (P = 0.009) and low ADC values (≤0.87 × 10−3 mm2s−1, P < 0.001) yielded high specificity (80.0 %/80.0 %). The BI-RADS classification supplemented with information from DWI and T2-WI improved the diagnostic performance of the BI-RADS classification as sensitivity remained 100 % and specificity improved from 30 % to 65.0 %. The numbers of false positive lesions declined from 39 % (N = 14) to 19 % (N = 7).

Conclusion

MRI-detected incidental lesions may be challenging to characterize as they have few specific malignancy indicating features. The specificity of MRI can be improved by incorporating T2 SI and ADC values into the BI-RADS assessment.

Key Points

MRI-detected incidental lesions have few specific malignancy indicating features.
≥ 1 suspicious morphologic or kinetic feature may warrant biopsy.
T2 signal intensity and DWI assessment are feasible in primarily MRI-detected lesions.
T2 SI and DWI assessment improve the BI-RADS specificity in MRI-detected lesions.
Literatur
1.
Zurück zum Zitat Teifke A, Lehr HA, Vomweg TW, Hlawatsch A, Thelen M (2003) Outcome analysis and rational management of enhancing lesions incidentally detected on contrast-enhanced MRI of the breast. AJR Am J Roentgenol 181:655–662CrossRefPubMed Teifke A, Lehr HA, Vomweg TW, Hlawatsch A, Thelen M (2003) Outcome analysis and rational management of enhancing lesions incidentally detected on contrast-enhanced MRI of the breast. AJR Am J Roentgenol 181:655–662CrossRefPubMed
2.
Zurück zum Zitat Brown J, Smith RC, Lee CH (2001) Incidental enhancing lesions found on MR imaging of the breast. AJR Am J Roentgenol 176:1249–1254CrossRefPubMed Brown J, Smith RC, Lee CH (2001) Incidental enhancing lesions found on MR imaging of the breast. AJR Am J Roentgenol 176:1249–1254CrossRefPubMed
3.
Zurück zum Zitat Peters NH, van Esser S, van den Bosch MA et al (2011) Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET—randomised controlled trial. Eur J Cancer 47:879–886CrossRefPubMed Peters NH, van Esser S, van den Bosch MA et al (2011) Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET—randomised controlled trial. Eur J Cancer 47:879–886CrossRefPubMed
4.
Zurück zum Zitat Gonzalez V, Sandelin K, Karlsson A, Åberg W, Löfgren L, Gabriela Iliescu G et al (2014) Preoperative MRI of the Breast (POMB) influences primary treatment in breast cancer: a prospective, randomized, multicenter study. World J Surg 38:1685–1693CrossRefPubMed Gonzalez V, Sandelin K, Karlsson A, Åberg W, Löfgren L, Gabriela Iliescu G et al (2014) Preoperative MRI of the Breast (POMB) influences primary treatment in breast cancer: a prospective, randomized, multicenter study. World J Surg 38:1685–1693CrossRefPubMed
5.
Zurück zum Zitat Turnbull L, Brown S, Harvey I, Olivier C, Drew P, Napp V et al (2010) Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 375:563–571CrossRefPubMed Turnbull L, Brown S, Harvey I, Olivier C, Drew P, Napp V et al (2010) Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 375:563–571CrossRefPubMed
6.
Zurück zum Zitat Langer SA, Horst KC, Ikeda DM, Daniel BL, Kong CS, Dirbas FM (2005) Pathologic correlates of false positive breast magnetic resonance imaging findings: which lesions warrant biopsy? Am J Surg 190:633–640CrossRefPubMed Langer SA, Horst KC, Ikeda DM, Daniel BL, Kong CS, Dirbas FM (2005) Pathologic correlates of false positive breast magnetic resonance imaging findings: which lesions warrant biopsy? Am J Surg 190:633–640CrossRefPubMed
7.
Zurück zum Zitat Bluemke DA, Gatsonis CA, Chen MH, DeAngelis GA, DeBruhl N, Harms S et al (2004) Magnetic resonance imaging of the breast prior to biopsy. JAMA 292:2735–2742CrossRefPubMed Bluemke DA, Gatsonis CA, Chen MH, DeAngelis GA, DeBruhl N, Harms S et al (2004) Magnetic resonance imaging of the breast prior to biopsy. JAMA 292:2735–2742CrossRefPubMed
8.
Zurück zum Zitat Linda A, Zuiani C, Londero V, Bazzocchi M (2008) Outcome of initially only magnetic resonance mammography-detected findings with and without correlate at second-look sonography: distribution according to patient history of breast cancer and lesion size. Breast 17:51–57CrossRefPubMed Linda A, Zuiani C, Londero V, Bazzocchi M (2008) Outcome of initially only magnetic resonance mammography-detected findings with and without correlate at second-look sonography: distribution according to patient history of breast cancer and lesion size. Breast 17:51–57CrossRefPubMed
9.
Zurück zum Zitat LaTrenta LR, Menell JH, Morris EA, Abramson AF, Dershaw DD, Liberman L (2003) Breast lesions detected with MR imaging: utility and histopathologic importance of identification with US. Radiology 227:856–861CrossRefPubMed LaTrenta LR, Menell JH, Morris EA, Abramson AF, Dershaw DD, Liberman L (2003) Breast lesions detected with MR imaging: utility and histopathologic importance of identification with US. Radiology 227:856–861CrossRefPubMed
10.
Zurück zum Zitat Morris EA, Comstock CE, Lee CH et al (2013) ACR BI-RADS® Magnetic Resonance Imaging. In: ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System. Reston, VA, American College of Radiology Morris EA, Comstock CE, Lee CH et al (2013) ACR BI-RADS® Magnetic Resonance Imaging. In: ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System. Reston, VA, American College of Radiology
11.
Zurück zum Zitat Orel SG, Schnall MD (2001) MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 220:13–30CrossRefPubMed Orel SG, Schnall MD (2001) MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 220:13–30CrossRefPubMed
12.
Zurück zum Zitat Kuhl CK, Klaschik S, Mielcarek P, Gieseke J, Wardelmann E, Schild HH (1999) Do T2 weighted pulse sequences help with the differential diagnosis of enhancing lesions in dynamic breast MRI? J Magn Reson Imaging 9:187–196CrossRefPubMed Kuhl CK, Klaschik S, Mielcarek P, Gieseke J, Wardelmann E, Schild HH (1999) Do T2 weighted pulse sequences help with the differential diagnosis of enhancing lesions in dynamic breast MRI? J Magn Reson Imaging 9:187–196CrossRefPubMed
13.
Zurück zum Zitat Schnall MD, Blume J, Bluemke DA, DeAngelis GA, DeBruhl N, Harms S et al (2006) Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology 238:42–53CrossRefPubMed Schnall MD, Blume J, Bluemke DA, DeAngelis GA, DeBruhl N, Harms S et al (2006) Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology 238:42–53CrossRefPubMed
14.
Zurück zum Zitat Fischer U, Kopka L, Grabbe E (1999) Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213:881–888CrossRefPubMed Fischer U, Kopka L, Grabbe E (1999) Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213:881–888CrossRefPubMed
15.
Zurück zum Zitat Baum F, Fischer U, Vosshenrich R, Grabbe E (2002) Classification of hypervascularized lesions in CE MR imaging of the breast. Eur Radiol 12:1087–1092CrossRefPubMed Baum F, Fischer U, Vosshenrich R, Grabbe E (2002) Classification of hypervascularized lesions in CE MR imaging of the breast. Eur Radiol 12:1087–1092CrossRefPubMed
16.
Zurück zum Zitat Tozaki M, Igarashi T, Matsushima S, Fukuda K (2005) High-spatial-resolution MR imaging of focal breast masses: interpretation model based on kinetic and morphological parameters. Radiat Med 23:43–50PubMed Tozaki M, Igarashi T, Matsushima S, Fukuda K (2005) High-spatial-resolution MR imaging of focal breast masses: interpretation model based on kinetic and morphological parameters. Radiat Med 23:43–50PubMed
17.
Zurück zum Zitat Ikeda DM, Hylton NM, Kinkel K, Hochman MG, Kuhl CK, Kaiser WA et al (2001) Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies. J Magn Reson Imaging 13:889–895CrossRefPubMed Ikeda DM, Hylton NM, Kinkel K, Hochman MG, Kuhl CK, Kaiser WA et al (2001) Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies. J Magn Reson Imaging 13:889–895CrossRefPubMed
18.
19.
Zurück zum Zitat Baltzer PA, Dietzel M, Kaiser WA (2013) A simple and robust classification tree for differentiation between benign and malignant lesions in MR-mammography. Eur Radiol 23:2051–2060CrossRefPubMed Baltzer PA, Dietzel M, Kaiser WA (2013) A simple and robust classification tree for differentiation between benign and malignant lesions in MR-mammography. Eur Radiol 23:2051–2060CrossRefPubMed
20.
Zurück zum Zitat Yamaguchi K, Schacht D, Sennett CA, Newstead GM, Imaizumi T, Irie H et al (2013) Decision making for breast lesions initially detected at contrast-enhanced breast MRI. AJR Am J Roentgenol 201:1376–1385CrossRefPubMed Yamaguchi K, Schacht D, Sennett CA, Newstead GM, Imaizumi T, Irie H et al (2013) Decision making for breast lesions initially detected at contrast-enhanced breast MRI. AJR Am J Roentgenol 201:1376–1385CrossRefPubMed
21.
Zurück zum Zitat Zhu Y, Zhang S, Liu P, Hong L, Xu Y, Yang WT (2012) Solitary intraductal papillomas of the breast: MRI features and differentiation from small invasive ductal carcinomas. Am J Roentgenol 199:936–942CrossRef Zhu Y, Zhang S, Liu P, Hong L, Xu Y, Yang WT (2012) Solitary intraductal papillomas of the breast: MRI features and differentiation from small invasive ductal carcinomas. Am J Roentgenol 199:936–942CrossRef
22.
Zurück zum Zitat Partridge SC, Demartini WB, Kurland BF, Eby PR, White SW, Lehman CD (2010) Differential diagnosis of mammographically and clinically occult breast lesions on diffusion-weighted MRI. J Magn Reson Imaging 31:562–570CrossRefPubMed Partridge SC, Demartini WB, Kurland BF, Eby PR, White SW, Lehman CD (2010) Differential diagnosis of mammographically and clinically occult breast lesions on diffusion-weighted MRI. J Magn Reson Imaging 31:562–570CrossRefPubMed
23.
Zurück zum Zitat Parsian S, Rahbar H, Allison KH, Demartini WB, Olson ML, Lehman CD, Partridge SC Nonmalignant breast lesions: ADCs of benign and high-risk subtypes assessed as false-positive at dynamic enhanced MR imaging. 265(3):696–706. doi:10.1148/radiol.12112672 Parsian S, Rahbar H, Allison KH, Demartini WB, Olson ML, Lehman CD, Partridge SC Nonmalignant breast lesions: ADCs of benign and high-risk subtypes assessed as false-positive at dynamic enhanced MR imaging. 265(3):696–706. doi:10.​1148/​radiol.​12112672
24.
Zurück zum Zitat Arponen O, Sudah M, Masarwah A, Taina M, Rautiainen S, Könönen M et al (2015) Diffusion-weighted imaging in 3.0 Tesla breast MRI: diagnostic performance and tumor characterization using small subregions vs. whole tumor regions of interest. PLoS ONE 10:e0138702CrossRefPubMed Arponen O, Sudah M, Masarwah A, Taina M, Rautiainen S, Könönen M et al (2015) Diffusion-weighted imaging in 3.0 Tesla breast MRI: diagnostic performance and tumor characterization using small subregions vs. whole tumor regions of interest. PLoS ONE 10:e0138702CrossRefPubMed
25.
Zurück zum Zitat Sardanelli F, Boetes C, Borisch B et al (2010) Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer 46:1296–1316CrossRefPubMed Sardanelli F, Boetes C, Borisch B et al (2010) Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer 46:1296–1316CrossRefPubMed
27.
Zurück zum Zitat Lalkhen AG, McCluskey A (2008) Clinical tests: sensitivity and specificity. Contin Educ Anaesth Crit Care Pain 8:221–223CrossRef Lalkhen AG, McCluskey A (2008) Clinical tests: sensitivity and specificity. Contin Educ Anaesth Crit Care Pain 8:221–223CrossRef
28.
Zurück zum Zitat Ballesio L, Savelli S, Angeletti M, Porfiri LM, D’Ambrosio I, Maggi C et al (2009) Breast MRI: Are T2 IR sequences useful in the evaluation of breast lesions? Eur J Radiol 71:96–101CrossRefPubMed Ballesio L, Savelli S, Angeletti M, Porfiri LM, D’Ambrosio I, Maggi C et al (2009) Breast MRI: Are T2 IR sequences useful in the evaluation of breast lesions? Eur J Radiol 71:96–101CrossRefPubMed
29.
Zurück zum Zitat Yuen S, Uematsu T, Kasami M et al (2007) Breast carcinomas with strong high-signal intensity on T2-weighted MR images: pathological characteristics and differential diagnosis. J Magn Reson Imaging 25:502–510CrossRefPubMed Yuen S, Uematsu T, Kasami M et al (2007) Breast carcinomas with strong high-signal intensity on T2-weighted MR images: pathological characteristics and differential diagnosis. J Magn Reson Imaging 25:502–510CrossRefPubMed
30.
Zurück zum Zitat El Khouli RH, Jacobs MA, Mezban SD, Huang P, Kamel IR, Macura KJ et al (2010) Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging. Radiology 256:64–73CrossRef El Khouli RH, Jacobs MA, Mezban SD, Huang P, Kamel IR, Macura KJ et al (2010) Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging. Radiology 256:64–73CrossRef
31.
Zurück zum Zitat Pinker K, Bickel H, Helbich TH, Gruber S, Dubsky P, Pluschnig U et al (2013) Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the “Breast Imaging Reporting and Data System” for multiparametric 3-T imaging of breast lesions. Eur Radiol 23:1791–1802CrossRefPubMed Pinker K, Bickel H, Helbich TH, Gruber S, Dubsky P, Pluschnig U et al (2013) Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the “Breast Imaging Reporting and Data System” for multiparametric 3-T imaging of breast lesions. Eur Radiol 23:1791–1802CrossRefPubMed
32.
Zurück zum Zitat Baltzer PA, Dietzel M, Kaiser WA (2011) Nonmass lesions in magnetic resonance imaging of the breast: additional T2-weighted images improve diagnostic accuracy. J Comput Assist Tomogr 35:361–366CrossRefPubMed Baltzer PA, Dietzel M, Kaiser WA (2011) Nonmass lesions in magnetic resonance imaging of the breast: additional T2-weighted images improve diagnostic accuracy. J Comput Assist Tomogr 35:361–366CrossRefPubMed
33.
Zurück zum Zitat Abe H, Schmidt RA, Shah RN et al (2010) MR- directed (“Second-Look”) US examination for breast lesions detected initially on MRI: MR and sonographic findings. AJR Am J Roentgenol 194:370–377CrossRefPubMed Abe H, Schmidt RA, Shah RN et al (2010) MR- directed (“Second-Look”) US examination for breast lesions detected initially on MRI: MR and sonographic findings. AJR Am J Roentgenol 194:370–377CrossRefPubMed
34.
Zurück zum Zitat Nunes LW, Schnall MD, Orel SG (2001) Update of breast MR imaging architectural interpretation model. Radiology 219:484–494CrossRefPubMed Nunes LW, Schnall MD, Orel SG (2001) Update of breast MR imaging architectural interpretation model. Radiology 219:484–494CrossRefPubMed
35.
36.
Zurück zum Zitat Partridge SC, Mullins CD, Kurland BF, Allain MD, DeMartini WB, Eby PR et al (2010) Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size. AJR Am J Roentgenol 194:1664–1673CrossRefPubMed Partridge SC, Mullins CD, Kurland BF, Allain MD, DeMartini WB, Eby PR et al (2010) Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size. AJR Am J Roentgenol 194:1664–1673CrossRefPubMed
37.
Zurück zum Zitat Spick C, Pinker-Domenig K, Rudas M, Helbich TH, Baltzer PA (2014) MRI-only lesions: application of diffusion- weighted imaging obviates unnecessary MR-guided breast biopsies. Eur Radiol 24:1204–1210CrossRefPubMed Spick C, Pinker-Domenig K, Rudas M, Helbich TH, Baltzer PA (2014) MRI-only lesions: application of diffusion- weighted imaging obviates unnecessary MR-guided breast biopsies. Eur Radiol 24:1204–1210CrossRefPubMed
38.
Zurück zum Zitat Yabuuchi H, Matsuo Y, Sunami S, Kamitani T, Kawanami S, Setoguchi T et al (2011) Detection of non-palpable breast cancer in asymptomatic women by using unenhanced diffusion-weighted and T2-weighted MR imaging: comparison with mammography and dynamic contrast-enhanced MR imaging. Eur Radiol 21:11–17CrossRefPubMed Yabuuchi H, Matsuo Y, Sunami S, Kamitani T, Kawanami S, Setoguchi T et al (2011) Detection of non-palpable breast cancer in asymptomatic women by using unenhanced diffusion-weighted and T2-weighted MR imaging: comparison with mammography and dynamic contrast-enhanced MR imaging. Eur Radiol 21:11–17CrossRefPubMed
39.
Zurück zum Zitat Baltzer PA, Benndorf M, Dietzel M, Gajda M, Camara O, Kaiser WA (2010) Sensitivity and specificity of unenhanced MR mammography (DWI combined with T2-weighted TSE imaging, ueMRM) for the differentiation of mass lesions. Eur Radiol 20:1101–1110CrossRefPubMed Baltzer PA, Benndorf M, Dietzel M, Gajda M, Camara O, Kaiser WA (2010) Sensitivity and specificity of unenhanced MR mammography (DWI combined with T2-weighted TSE imaging, ueMRM) for the differentiation of mass lesions. Eur Radiol 20:1101–1110CrossRefPubMed
40.
Zurück zum Zitat Debald M, Abramian A, Nemes L, Döbler M, Kaiser C, Keyver-Paik MD et al (2015) Who may benefit from preoperative breast MRI? A single-center analysis of 1102 consecutive patients with primary breast cancer. Breast Cancer Res Treat 1 Debald M, Abramian A, Nemes L, Döbler M, Kaiser C, Keyver-Paik MD et al (2015) Who may benefit from preoperative breast MRI? A single-center analysis of 1102 consecutive patients with primary breast cancer. Breast Cancer Res Treat 1
41.
Zurück zum Zitat Lim HI, Choi JH, Yang JH, Han BK, Lee JE, Lee SK et al (2010) Does pre-operative breast magnetic resonance imaging in addition to mammography and breast ultrasonography change the operative management of breast carcinoma? Breast Cancer Res Treat 119:163–167CrossRefPubMed Lim HI, Choi JH, Yang JH, Han BK, Lee JE, Lee SK et al (2010) Does pre-operative breast magnetic resonance imaging in addition to mammography and breast ultrasonography change the operative management of breast carcinoma? Breast Cancer Res Treat 119:163–167CrossRefPubMed
42.
Zurück zum Zitat Clauser P, Marcon M, Maieron M, Zuiani C, Bazzocchi M, Baltzer PA (2015) Is there a systematic bias of apparent diffusion coefficient (ADC) measurements of the breast if measured on different workstations? An inter- and intra-reader agreement study. Eur Radiol Clauser P, Marcon M, Maieron M, Zuiani C, Bazzocchi M, Baltzer PA (2015) Is there a systematic bias of apparent diffusion coefficient (ADC) measurements of the breast if measured on different workstations? An inter- and intra-reader agreement study. Eur Radiol
43.
Zurück zum Zitat Giannotti E, Waugh S, Priba L, Davis Z, Crowe E, Vinnicombe S (2015) Assessment and quantification of sources of variability in breast apparent diffusion coefficient (ADC) measurements at diffusion weighted imaging. Eur J Radiol 84:1729–1736CrossRefPubMed Giannotti E, Waugh S, Priba L, Davis Z, Crowe E, Vinnicombe S (2015) Assessment and quantification of sources of variability in breast apparent diffusion coefficient (ADC) measurements at diffusion weighted imaging. Eur J Radiol 84:1729–1736CrossRefPubMed
44.
Zurück zum Zitat Chen X, Li WL, Zhang YL, Wu Q, Guo YM, Bai ZL (2010) Meta-analysis of quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesions. BMC Cancer 10:693CrossRefPubMedPubMedCentral Chen X, Li WL, Zhang YL, Wu Q, Guo YM, Bai ZL (2010) Meta-analysis of quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesions. BMC Cancer 10:693CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Belli G, Busoni S, Ciccarone A, Coniglio A, Esposito M et al (2015) Quality assurance multicenter comparison of different MR scanners for qualitative diffusion-weighted imaging. J Magn Reson Imaging 00:1–7 Belli G, Busoni S, Ciccarone A, Coniglio A, Esposito M et al (2015) Quality assurance multicenter comparison of different MR scanners for qualitative diffusion-weighted imaging. J Magn Reson Imaging 00:1–7
Metadaten
Titel
Incidentally detected enhancing lesions found in breast MRI: analysis of apparent diffusion coefficient and T2 signal intensity significantly improves specificity
verfasst von
Otso Arponen
Amro Masarwah
Anna Sutela
Mikko Taina
Mervi Könönen
Reijo Sironen
Juhana Hakumäki
Ritva Vanninen
Mazen Sudah
Publikationsdatum
25.04.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 12/2016
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-016-4326-2

Weitere Artikel der Ausgabe 12/2016

European Radiology 12/2016 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.